Some aspects of Mycobacterium leprae biology
Journal Title: Postępy Nauk Medycznych - Year 2011, Vol 24, Issue 10
Abstract
Mycobacterium leprae was the first bacterium shown to be associated with disease in humans through the work of Hansen in the 1870s, but the sources of infection, mode of transmission and early pathogenesis of infection remain an enigma.Actually, leprosy remains an important health problem worldwide existing in many developing countries and many features of its determinants are still obscure. The disease is caused by a chronic granulomatous infection of the skin and peripheral nerves. Several features distinguish M. leprae from other members of mycobacterium genus: 1. loss of acid-fasness upon extraction with pyridine, 2. ability to oxidize 3,4-dihydroxyphenylalanine, 3. replacement of L-alanine with glycine in the linking peptide of peptoglican, 4. 56% GC content as compared with 65-70% for most Mycobacterium species, 5. lack of substantial genomic DNA homology with other Mycobacterium species. The systematic use of multidrug therapy (MDT), as recommended by WHO Study Group in 1982 is highly effective for all forms of disease. The widespread implementation of MDT has been associated with a fall in the prevalence of leprosy but as yet no reduction in the case-detection rate globally. Because of lack of laboratory tools to detect leprosy in its very early stage it is difficult to measure the main epidemiological indicators – annual incidence and new case detection rate. The global elimination strategy will be revised taking new molecular epidemiology knowledge into account. In laboratory Mycobacterium leprae is detected by Ziehl-Neelsen stain method, PCR, Hein-test, level of dihydroxyphenyalanine oxidise and cultivation on the feet of mice or on nine banded armadillos.
Authors and Affiliations
Ewa Augustynowicz-Kopeć, Zofia Zwolska
Keywords
Related Articles
- EP ID EP54063
- DOI -
- Views 175
- Downloads 0
Chromogranin A (CgA): structure, biological function, pre-analytical, analytical, and clinical aspects of its measurement in blood
Chromogranin A (CgA) is a main nonspecific neuroendocrine tumour (NET) marker. Currently few commercial assays are available: RIA, IRMA, ELISA, CLIA, TRACE. There are many factors: in vivo, in vitro and coexisting diseas...
Składniki immunomodulujące i immunostymulujące w diecie dzieci i młodzieży z otyłością prostą
Wstęp. Prawidłowo zbilansowana dieta pod względem zawartości makroskładników, składników mineralnych oraz witamin jest niezbędna do uzyskania optymalnej odporności.Cel pracy. Celem pracy była ocena spożycia z dietą skład...
Interstitial lung disease in the most frequently appearing connective tissue diseases – rheumatoid arthritis and systemic lupus erythematosus
Connective tissue diseases are systemic autoimmune disorders that principally affect the joints. Pulmonary complications are common and although they usually occur after the onset of joint symptoms, they can also be init...
Rak wątrobowokomórkowy – rola leczenia chirurgicznego z uwzględnieniem zasad kwalifikacji do przeszczepiania wątroby
Rak wątrobowokomórkowy jest złośliwym nabłonkowym guzem stanowiącym około 80% wszystkich pierwotnych guzów wątroby. W epidemiologicznym rejestrze jest 5-tym co do częstości występującym nowotworem na świecie. W Polsce ob...
Podwyższony poziom troponiny I – czynnik złego rokowania w udarach niedokrwiennych mózgu
Wstęp. W ostrej fazie udaru niedokrwiennego mózgu (UNM) obserwuje się liczne zaburzenia kardiologiczne, przede wszystkim w zapisie krzywej EKG. Dodatkowym czynnikiem ryzyka wystąpienia zaburzeń kardiologicznych jest udar...